Literature DB >> 8648672

Folding, assembly, and intracellular trafficking of the human immunodeficiency virus type 1 envelope glycoprotein analyzed with monoclonal antibodies recognizing maturational intermediates.

A Otteken1, P L Earl, B Moss.   

Abstract

Monoclonal antibodies (MAbs) that bind linear or conformational epitopes on monomeric or oligomeric human immunodeficiency virus type 1 (HIV-1) envelope glycoproteins were screened for their recognition of maturational intermediates. On the basis of reactivities with gp160 at different times after pulse-labeling, the MAbs were sorted into groups that exhibited binding which was immediate and constant, immediate but transient, delayed, late, or very late. This grouping was consistent with the selectivity of the MAbs for structural features of gp160. Thus, a MAb to the V3 loop reacted with envelope proteins at all times, in accord with the relative conformational independence and accessibility of the epitope. Several MAbs that preferentially react with monomeric gp160 exhibited diminished binding after the pulse. A 10-min tag occurred before gp160 reacted with conformational MAbs that inhibited CD4 binding. The availability of epitopes for other conformational MAbs, including some that react equally with monomeric and oligomeric gp160 and some that react better with oligomeric forms, was half-maximal in 30 min and closely followed the kinetics of gp160 oligomerization. Remarkably, there was a 1- to 2-h delay before gp160 reacted with stringent oligomer-specific MAbs. After 4 h, approximately 20% of the gp160 was recognized by these MAbs. Epitopes recognized by monomerspecific or CD4-blocking MAbs but not by oligomer-dependent MAbs were present on gp160 molecules associated with the molecular chaperone BiP/GRP78. MAbs with a preference for monomers reacted with recombinant or HIV-1 envelope proteins in the endoplasmic reticulum, whereas the oligomer-specific MAbs recognized them in the Golgi complex. Additional information regarding gp160 maturation and intracellular trafficking was obtained by using brefeldin A, dithiothreitol, and a low temperature.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8648672      PMCID: PMC190213     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  CD4 is retained in the endoplasmic reticulum by the human immunodeficiency virus type 1 glycoprotein precursor.

Authors:  B Crise; L Buonocore; J K Rose
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

2.  Biological and immunological properties of human immunodeficiency virus type 1 envelope glycoprotein: analysis of proteins with truncations and deletions expressed by recombinant vaccinia viruses.

Authors:  P L Earl; S Koenig; B Moss
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

3.  Heavy chain binding protein recognizes incompletely disulfide-bonded forms of vesicular stomatitis virus G protein.

Authors:  C E Machamer; R W Doms; D G Bole; A Helenius; J K Rose
Journal:  J Biol Chem       Date:  1990-04-25       Impact factor: 5.157

Review 4.  Polypeptide chain binding proteins: catalysts of protein folding and related processes in cells.

Authors:  J E Rothman
Journal:  Cell       Date:  1989-11-17       Impact factor: 41.582

Review 5.  Perturbation of vesicular traffic with the carboxylic ionophore monensin.

Authors:  A M Tartakoff
Journal:  Cell       Date:  1983-04       Impact factor: 41.582

6.  Intracellular interaction of human immunodeficiency virus type 1 (ARV-2) envelope glycoprotein gp160 with CD4 blocks the movement and maturation of CD4 to the plasma membrane.

Authors:  M A Jabbar; D P Nayak
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

7.  Microtubule-dependent retrograde transport of proteins into the ER in the presence of brefeldin A suggests an ER recycling pathway.

Authors:  J Lippincott-Schwartz; J G Donaldson; A Schweizer; E G Berger; H P Hauri; L C Yuan; R D Klausner
Journal:  Cell       Date:  1990-03-09       Impact factor: 41.582

8.  Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells.

Authors:  C K Leonard; M W Spellman; L Riddle; R J Harris; J N Thomas; T J Gregory
Journal:  J Biol Chem       Date:  1990-06-25       Impact factor: 5.157

9.  Folding, interaction with GRP78-BiP, assembly, and transport of the human immunodeficiency virus type 1 envelope protein.

Authors:  P L Earl; B Moss; R W Doms
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

10.  The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus.

Authors:  A G Dalgleish; P C Beverley; P R Clapham; D H Crawford; M F Greaves; R A Weiss
Journal:  Nature       Date:  1984 Dec 20-1985 Jan 2       Impact factor: 49.962

View more
  30 in total

1.  Identification of two sequences in the cytoplasmic tail of the human immunodeficiency virus type 1 envelope glycoprotein that inhibit cell surface expression.

Authors:  A Bültmann; W Muranyi; B Seed; J Haas
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

2.  Only five of 10 strictly conserved disulfide bonds are essential for folding and eight for function of the HIV-1 envelope glycoprotein.

Authors:  Eelco van Anken; Rogier W Sanders; I Marije Liscaljet; Aafke Land; Ilja Bontjer; Sonja Tillemans; Alexey A Nabatov; William A Paxton; Ben Berkhout; Ineke Braakman
Journal:  Mol Biol Cell       Date:  2008-07-23       Impact factor: 4.138

3.  Role of the HIV gp120 conserved domain 1 in processing and viral entry.

Authors:  Jizhen Wang; Jayita Sen; Lijun Rong; Michael Caffrey
Journal:  J Biol Chem       Date:  2008-09-24       Impact factor: 5.157

4.  Evolution rescues folding of human immunodeficiency virus-1 envelope glycoprotein GP120 lacking a conserved disulfide bond.

Authors:  Rogier W Sanders; Shang-Te D Hsu; Eelco van Anken; I Marije Liscaljet; Martijn Dankers; Ilja Bontjer; Aafke Land; Ineke Braakman; Alexandre M J J Bonvin; Ben Berkhout
Journal:  Mol Biol Cell       Date:  2008-08-27       Impact factor: 4.138

5.  Folding of rabies virus glycoprotein: epitope acquisition and interaction with endoplasmic reticulum chaperones.

Authors:  Y Gaudin
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

6.  Human immunodeficiency virus type 1 envelope glycoprotein oligomerization requires the gp41 amphipathic alpha-helical/leucine zipper-like sequence.

Authors:  P Poumbourios; K A Wilson; R J Center; W El Ahmar; B E Kemp
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

7.  Human immunodeficiency virus type 1 and 2 envelope glycoproteins oligomerize through conserved sequences.

Authors:  R J Center; B E Kemp; P Poumbourios
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

8.  HIV-1 Envelope Glycoprotein Trafficking through the Endosomal Recycling Compartment Is Required for Particle Incorporation.

Authors:  Junghwa Kirschman; Mingli Qi; Lingmei Ding; Jason Hammonds; Krista Dienger-Stambaugh; Jaang-Jiun Wang; Lynne A Lapierre; James R Goldenring; Paul Spearman
Journal:  J Virol       Date:  2018-02-12       Impact factor: 5.103

9.  Conformational maturation and post-ER multisubunit assembly of gap junction proteins.

Authors:  Judy K Vanslyke; Christian C Naus; Linda S Musil
Journal:  Mol Biol Cell       Date:  2009-03-18       Impact factor: 4.138

10.  Role of the membrane-spanning domain of human immunodeficiency virus type 1 envelope glycoprotein in cell-cell fusion and virus infection.

Authors:  Liang Shang; Ling Yue; Eric Hunter
Journal:  J Virol       Date:  2008-03-19       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.